Prevalence of hypothyroidism in pregnancy and its feto-maternal outcome

Sharma V.1, Shukla N.2

1Dr. Varuni Sharma, Department of Obstetrics & Gynaecology, 2Dr. Navin Shukla, Department of Otorhinolaryngololgy & Head & Neck Surgery, both authors are affiliated with Subharti Medical College, Dehradun, Uttarakhand, India.

Correspondence Author: Dr. Varuni Sharma, Department of Obstetrics & Gynaecology, Subharti Medical College, Dehradun, Uttarakhand, India. E-mail: drvarunishukla@gmail.com


Abstract

Background: Thyroid disorders are among the most common endocrine disorders in pregnant females. Hypothyroidism is more common during pregnancy than hyperthyroidism. The overall prevalence of subclinical hypothyroidism in general population has been reported to be 4% -8.5% while overt hypothyroidism is 0.2 – 0.3% (2). Objective: To evaluate the prevalence of hypothyroidism in pregnancy and to determine association of feto-maternal outcome with hypothyroidism. Material and Methods: A Prospective study conducted over 120 patients who came to routine antenatal care and/or admitted in labour  room of Subharti Hospital, Dehradun over a period of 01 year. Women with singleton pregnancy irrespective of the period of gestation were randomly selected for the study. Patients thus selected were divided into two groups: Control Group: This comprised of pregnant females in whom serum TSH and FT4 levels were found to be within normal range on estimation. Study Group: This group included pregnant females who were diagnosed as cases of subclinical hypothyroidism on the basis of raised TSH and normal TF4 levels and overt hypothyroidism on basis of raised TSH and decreased TF4. Results: The prevalence of hypothyroidism came out to be 24.29%. Higher rate of still births, hyperbilirubinemia and admission to neonatal ICU (foetal distress, meconium stained liquor) in the hypothyroid group were observed. Conclusion: Hypothyroidismcontinues to be an important medical condition in pregnancy with significant feto-maternal morbidity. Due to the adverse effect of maternal thyroid disorder on maternal and fetal outcome, timely diagnosis and initiation of treatment of hypothyroid disorders is essential.

Keywords: Thyroid Dysfunction, Thyroid disorder, Pregnancy, Hypothyroidism, Outcome


Manuscript received: 20th December 2018 Reviewed: 30th December 2018
Author Corrected: 6th January 2019 Accepted for Publication: 10th January 2019

Introduction

Thyroid disorders are among the most common endocrine disorders in pregnant females. Hypothyroidism is more common during pregnancy than hyperthyroidism [1]. Pregnancy is associated with significant but reversible changes in maternal thyroid physiology that can lead to confusion on the diagnosis or evaluation of thyroid abnormalities.

Subclinical hypothyroidism is defined as increase in serum TSH usually (4-10Mu/L) associated with normal concentration of serum thyroxine and triiodothyronine.Overt hypothyroidism is diagnosed when high serum thyrotropin level is accompanied by abnormal low thyroxine level.

The overall prevalence of subclinical hypothyroidism in general population has been reported to be 4% -8.5% while overt hypothyroidism is 0.2 – 0.3 %[2]. Women with hypothyroidism can still conceive, although infertility rates are higher and failure of in vitro fertilization is more likely. Pregnant women with hypothyroidism have a greater risk of early and late obstetric complications such as miscarriage, anaemia, gestational hypertension, placental abruption, premature delivery, post-partumhaemorrhage and admission of their baby to neonatal intensive care (particularly for RDS)[3].

The detrimental effects of maternal thyroid deficiency on foetal development are thought to depend on the severity and early onset of a reduced availability of maternal thyroid hormones. Recent studies indicate that undiagnosed (and hence untreated) hypothyroidism during the first half of pregnancy is associated with a risk of poorer neurodevelopment outcome in the progeny [4].

Considering the wide-spread clinical implications of gestational sub & - clinical hypothyroidism and its sequelae, this study was planned to know the prevalence of hypothyroidism in pregnant women attending the antenatal care at Department of Obstetrics & Gynaecology of Subharti Hospital, Dehradun.

Material and Methods

Thestudy was conducted over 120 patientswho came to routine antenatal care or were admitted in labour room of Subharti Hospital, Dehradun over a period of one year (from 1st May 2015 to 30th April 2016).

Study design: Prospective study

Inclusion criteria

Among the pregnant women who attended antenatal clinic or were admitted in labour room, women with singleton pregnancy irrespective of the period of gestation were randomly selected for the study. Patients were divided into two groups:

1.    Control Group: This comprised of pregnant females in whom serum TSH and FT4 levels were found to be within normal range on estimation.

2.    Study Group: This group included pregnant females who were diagnosed as cases of subclinical hypothyroidism on the basis of raised TSH and normal TF4 levels and overt hypothyroidism on basis of raised TSH and decreased TF4.

10 cases were diagnosed as hypothyroid but had pregnancy loss were dropped out from the study as they could not be followed for maternal and fetal outcome

Exclusion criteria

1. Already diagnosed hypothyroidism.

2. Multiple pregnancy

3. Women on treatment for thyroid dysfunction

4. Any medical co morbidity

Study Protocol- All patients were registered at their first antenatal visit. At the time of registration detailed history was taken and general examination was done.

Blood was taken for estimation of S.TSH and FT4. Hb, ABO, Rh, RBS, HIV, HBsAg and urine R/M were done as a part of routine test.

Normal values taken in the present:

TSH:0.465-5.68 mIU/ml

FT4:10.0-28.2 pmol/L

After registering the patients, theywere followed up with routine antenatal visits up to delivery and records were reviewed for any signs of development of PIH, preterm delivery, low birth weight, placental abruption, recurrent pregnancy losses, still birth, congenital anomalies, admission of baby to neonatal ICU, foetal distress in labour and hyperbilirubinemia.

Estimation of TSH- The TSH assay was performed using the TSH reagent Pack and Immuno diagnostic products TSH Calibrators on the ECi. Immunodiagnostic System. An immunometric assay technique was used.

Serum, EDTA or heparin plasma was recommended.

Estimation of free T4- The free T4 assay was performed using the free T4 calibrators on the ECi Immunodiagnostic system.

Statistical Analysis- For statistical analysis Percentage, Proportion, Chi square test were used.Once the values of chi square-tests are calculated the corresponding values of 'p' will be obtained using the standard tales are per degree of freedom and the significance graded as:

p value                  Results significance

< 0.05 to 0.01       statistically significant

Results

Table-1: Distribution of cases according to association with PIH in patients

Variable

Control group (n=81)

Study group (n=19)

P Value

PIH

Present

17 (20.9%)

9 (47.36%)

0.01

Not present

64 (79.1%)

10 (52.63%)

The patients (n=100) were divided into 2 groups: Control group & Study group. In control group, 17 (20.90%) of patients had PIH whereas in study group 9 (47.36%) had PIH. The difference between both groups was statistically significant in relation to the presence/absence of PIH.

Table-2: Association of hypothyroidism with Bad Obstetric History & Diabetes

Risk Factor

Control group (n=81)

Study group (n=19)

P Value

Bad obstetric history

Present

13 (16.04%)

7 (36.84%)

0.04

Not present

68 (83.95%)

12 (63.16%)

Diabetes

Present

1 (1.23%)

2(10.5%)

<0.05

Not present

80 (98.76%)

17(89.47%)

Table 2 shows the relationship of screening for detection of hypothyroidism with high risk factor. Out of 100 patient underwent screening, 13patients from control group and 7 patients from study group showed risk factor such as, bad obstetrics history such as still birth or recurrent abortions. Diabetes was present in 1 patient from control group and in 2 patients from study group.

On statistical analysis the correlation was found to be significant (p<0.05) patients with history of Type-I DM and BOH.

Table-3: Distribution of cases according to association with placental abruption

Variables

Control group (n=81)

Study group

(n=19)

P Value

Placental abruption

Present

7 (8.68%)

4 (21.1%)

0.119

Absent

74 (91.35%)

15 (78.9%)

Mode of delivery

Vaginal delivery

65 (80.24%)

11 (57.89%)

<0.05

Caesarean

16 (19.76%)

8 (42.11%)

Gestational age of delivery

<34 weeks

8 (9.87%)

8 (42.11%)

0.03

>34 weeks

73 (90.12%)

11 (57.89%)

Incidence of low birth weight

<2 kg

5 (6.17%)

6 (31.6%)

<0.002

2-2.5kg

46 (56.8%)

9 (47.1%)

<0.005

>2.5 kg

30 (37.1%)

4 (21.1%)

P > 0.05

Comparing the control group and study group on the basis of distribution of cases, Placental abruption was present in 7 (8.68%) patients of control group and 4 (21.1%) patients of study group. There was a statistically significant difference observed in Vaginal delivery and Caesarean of both groups with p value<0.05 also, the difference was significant for gestational age of delivery <34 weeks &>34 weeks in both groups. As per the incidence of low birth weight, 5 patients of Control group& 6 patients of study group has weight <2 kg, 46 patients of Control group & 9 patients of study group has weight 2-2.5kg, 30 patients of Control group & 4 patients of study group has weight >2.5 kg.

Table-4: Relationship of hypothyroidism with foetal distress in labour

Variables

Control group (n=81)

Study group (n=19)

P Value

Foetal distress, MSAF & other

25 (30.86%)

9 (47.36%)

<0.05

No foetal distress

56 (69.13%)

10 (52.63%)

Foetal distress, MSAF was observed in 25 patients of control group and in 9 patients of study group. On statistical analysis the result was found to be significant P < 0.05.

Table-5: Neonatal outcomes in patients with hypothyroidism in comparison to normal patients

Outcome

Control group (n=81)

Study group (n=19)

P Value

Still birth

2 (2.46%)

3 (15.8%)

<0.05 Z = 1.81

Congenital anomaly

0 (0%)

1 (5.3%)

>0.05

Admission to ICU

14 (17.3%)

8 (42.1%)

<0.05 Z = 2.03

Hyperbilirubinemia

9 (11.11%)

6 (31.57%)

<0.05

On statistical analysis the incidence of still births and ICU admission rates &hyperbilirubinemia were found to be significant between two groups.

Discussion

Considering the widespread clinical implications of gestational hypothyroidism and its sequelae, the present study was aimed to study the prevalence of hypothyroidism in pregnancy and its feto-maternal outcomes. The study was carried out on 107 patients, who presented to antenatal care in Subharti Hospital Dehradun over a period of one year from 1st May 2015 to 30thApril 2016. The women were followed up till delivery. The study population consisted of 81 normal patients and 19 hypothyroid patients diagnosed and followed up. 7 hypothyroid patients were dropped out from study. In our study, the prevalence of hypothyroidism came out to be 24.29% while in a study by Saki F et al. found the prevalence of hypothyroidism13.7% out of which 2.4% was clinical and 11.3% was sub-clinical [5]. Another study by Sahu HT et al. noted that the prevalence of thyroid dysfunction was high, with subclinical hypothyroidism in 6.47% and overt hypothyroidism in 4.58% women [6]. The variation in prevalence of hypothyroidism may be due to difference in defined normal range of TSH.

Considering the distribution of cases in study population, in the study group, 19 women were included, these were the women who were diagnosed as hypothyroid on the basis of serum TSH and Free T4 levels. In control group, 81 women who had normal thyroid function test on screening. They included the remaining 81 patients of study population.

Distribution of cases according to association with PIH

The present study shows 47.36% cases of PIH in patients diagnosed as hypothyroidism patients in study group compared to 20.9% incidence of PIH in patients in control group (P value 0.01- significant). Similar results were observed by Sahu HT, Das V Mittal et al (2010), Aziz Nuzhat et al. in 2006,Kumar Ashok, Ghosh B.K. et al [6,7,8].

Relationship of Screening for hypothyroidism with individual high risk factors

Positive correlation was found between risk factors as bad obstetric history and Type - I diabetes. 35% with BOH developed hypothyroidism which was statistically significant with P<0.05.16 patients, out of 19 hypothyroid patients in the study group had one or the other risk factor, whereas 3 patients (15.78%) were without any risk factors.De vivo et al also found that the occurrence and timing of pregnancy loss is related to hypothyroidism [9]. Bijay Viadyaet al. showed that the prevalence of raised TSH was higher in the high risk group [10].

Study by Brain M. Casey, Jodi S. Dash et al in 2005 showed that pregnancy in women with subclinical hypothyroidism was three times more likely to be complicated by placental abruption when compared with healthy pregnant women [11]. Similar results were shown by Goel P, et al in their study on 30 patients with subclinical hypothyroidism in 2005. They found an incidence of 0.3% placental abruption in their study group which was not significant[12].

Comparison of mode of delivery in the control and study groups

In the present study, we found that 8 out of 19 (42.11%) in the study groupcompared to 16 of 81 (19.76%) patients in the control group were delivered by caesarean section as on statistical analysis the difference was significant (p<0.05). Comparable results were shown in a study by Sahu HT, Das V Mittal et al (2010), Iskandar Idris, Ramalingam Srinivasan et al. in 2005 [6,13].

Comparison of preterm birth in control and study group

The present study showed preterm birth defined as delivery before 34 weeks42.11% in the study group compared to 9.87% of controls, which was found to be statistically significant with p<0.05 (p value 0.003). Study by Brain M. Casey, Jodi S et al in 2005Aziz Nuzhat, Reddi Pranathi et al in 2006 also showed increased incidence of preterm delivery in hypothyroid group [7,14].

Comparison of cases according to birth weights

The present study showed significant proportion of babies having low birth weight 31.6% of infants weighed <2.0kg in the study group as compared to 6.17% of the control group (p value 0.002). Similar results were observed in studies conducted by Aziz Nuzhat et al., Idris I., Srinivasan et al[7,13]. Another similar study by Goel P et al. showed 13.3% incidence of low birth weight with 20% evidence of foetal distress[12].

Comparison of cases according to fetal distress

The present study showed 47.36% of study group having foetal distress in labour, 3 babies out of 19 had still birth that is 15.8% and 1 out of 19 had congenital anomalies i.e.5.3%. The foetal distress was found to be significant (p<0.05) in relation to the control group and were comparable to the studies by Brain M Casey et al.which showed that admission to the neonatal intensive care nursery and respiratory distress were twice as likely in infants delivered of women with sub clinical hypothyroidism [14]. Another similar study by Goel P et al. observed 13.3% incidence of low birth weight and 20% had evidence of foetal distress [12].

Considering the above feto-maternal complications the most practical approach is to screen all pregnant women for hypothyroidism as early in pregnancy as possible (on before conception). In the case of the mother, screening would result in early diagnosis and treatment of hypothyroidism. The implications are staggering when one considers that there is a significant increase in intrauterine deaths, spontaneous abortions, premature births and pre-eclampsia in women with gestational hypothyroidism.

In the infant, major malformation and loss of IQ could be prevented by early diagnosis and treatment of the mother. It is believed that if screening of all pregnant women in implemented, the mother, the infant and society will all benefit.

Conclusion

A total of 107 patients were included in the study and were screened by estimation of serum TSH and FT4 to determine the presence of hypothyroidism. Only 100 women were followed up from their antenatal visit up till delivery Feto-maternal outcome of these patients was recorded, while 7 were dropped out because of early pregnancy loss. The salient observations made in this study are as follows:

·   The prevalence of hypothyroidism was 24.29% in this study.

·   The present study concluded that history of recurrent pregnancy loss and diabetes are significantly associated with hypothyroidism.

·   The study showed that there was increased rate of gestational hypertension, preeclampsia, preterm delivery and low birth weight babies in hypothyroid group which was statistically significant.

·   The study also showed that rate of foetal distress during labour (47.36% Vs 30.86%) was also high and hence rate of emergency caesarean section (42.11 Vs 19.76%) was high in hypothyroid group. This value is also statistically significant.

·   The study also showed that there was higher rate of still births, hyper bilirubinaemia and admission to neonatal ICU (foetal distress, meconium stained liquor) in the hypothyroid group.

What this study adds to existing knowledge

The present study therefore concludes that hypothyroidism continues to be an important medical condition in pregnancy with significant feto-maternal morbidity. This study therefore recommends that early identification and proper management of this condition is the only intervention to ameliorate and decrease is attendant morbidity and mortality.    

References

1. Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am. 2001 Jun;30(2):245-64, vii.[pubmed]

2. McLeod D, McIntyre H. Subclinical hypothyroidism and related biochemical entities in pregnancy: implications and management. Obstetric Medicine. 2010;3(4):139-144.

3. Tudosa R, Vartej P, Horhoianu I, Ghica C, Mateescu S, Dumitrache I. Maternal and fetal complications of the hypothyroidism-related pregnancy. Maedica (Buchar). 2010;5(2):116-123.

4. Kumar A, Singh R, Prasad S. Hypothyroidism during pregnancy. International Journal of Gynecology& Obstetrics. 2003;84(3):252-253.

5. Saki F, Dabbaghmanesh M, Ghaemi S, Forouhari S, RanjbarOmrani G, Bakhshayeshkaram M. Thyroid Function in Pregnancy and Its Influences on Maternal and Fetal Outcomes. International Journal of Endocrinology and Metabolism. 2014;12(4).

6. Sahu MT, Das V, Mittal S, et al. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet. 2010 Feb;281(2):215-20. doi: 10.1007/s00404-009-1105-1. Epub 2009 May 13. [pubmed]

7. Nuzhat A, Pranathi R, Evita F. Hypothyroidism in pregnancy: Is universal screening needed?. J ObstetGynecol India. 2006;56(6):495-498.

8. Kumar A, Ghosh BK, Murthy NS. Maternal thyroid hormonal status in preeclampsia. Indian J Med Sci. 2005 Feb;59(2):57-63.[pubmed]

9. De Vivo A, Mancuso A, Giacobbe A, et al. Thyroid function in women found to have early pregnancy loss. Thyroid. 2010 Jun;20(6):633-7. doi: 10.1089/thy.2009.0323.[pubmed]

10. Vaidya B, Anthony S, Bilous M, et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding? J Clin Endocrinol Metab. 2007 Jan;92(1):203-7. Epub 2006 Oct 10. DOI:10.1210/jc.2006-1748.[pubmed]

11. Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005 Feb;105(2):239-45.[pubmed]

12. Goel P, Radotra A, Devi K, et al. Maternal and perinatal outcome in pregnancy with hypothyroidism. Indian J Med Sci. 2005 Mar;59(3):116-7.[pubmed]

13. Idris I, Srinivasan R, Simm A, et al. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol (Oxf). 2005 Nov;63(5):560-5.[pubmed]

14. Casey BM. Subclinical hypothyroidism and pregnancy. Obstet Gynecol Surv. 2006 Jun;61(6):415-20; quiz 423. DOI:10.1097/01.ogx.0000223331.51424.9b.[pubmed]


How to cite this article? 

Sharma V, Shukla N. Prevalence of hypothyroidism in pregnancy and its feto-maternal outcome. Obg Rev:J obstet Gynecol 2019;5(1):7-12.doi: 10.17511/jobg.2019.i1.02.